An Act to repeal 632.865 (2) and 632.865 (5) (e); to renumber 632.865 (4); to amend 40.51 (8), 40.51 (8m), 66.0137 (4), 120.13 (2) (g), 185.983 (1) (intro.), 609.83, 632.861 (4) (a), 632.865 (1) (ae) and 632.865 (6) (c) 3.; and to create 632.861 (1m), 632.861 (3g), 632.861 (3r), 632.861 (4) (e), 632.862, 632.865 (1) (ab) and (ac), 632.865 (1) (an), (aq), and (at), 632.865 (1) (bm), 632.865 (1) (cg) and (cr), 632.865 (2d), 632.865 (2h), 632.865 (2p), 632.865 (2t), 632.865 (4) (b), 632.865 (5d), (5h), (5p) and (5t), 632.865 (6) (bm), 632.865 (6) (c) 3m., 632.865 (6g), 632.865 (6r) and 632.865 (8) of the statutes; Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| Date / House | Action | Journal |
|---|---|---|
| 12/8/2023 Asm. | Introduced by Representatives Schraa, Rozar, Tittl, Conley, Dittrich, Donovan, Edming, Goeben, Goyke, Gundrum, Jacobson, Magnafici, Mursau, Novak, O'Connor, Oldenburg, Palmeri, Snyder, Tusler, Wichgers and Rettinger; cosponsored by Senators Felzkowski, Quinn, James, Pfaff and Taylor | |
| 12/8/2023 Asm. | Read first time and referred to Committee on Health, Aging and Long-Term Care | |
| 12/14/2023 Asm. | Fiscal estimate received | |
| 12/27/2023 Asm. | Representative Green added as a coauthor | |
| 12/28/2023 Asm. | Representative O'Connor withdrawn as a coauthor | |
| 1/17/2024 Asm. | Representative Armstrong added as a coauthor | |
| 2/6/2024 Asm. | Representative Allen added as a coauthor | |
| 2/12/2024 Asm. | Assembly Amendment 1 offered by Representative Schraa | |
| 2/12/2024 Asm. | Assembly Amendment 2 offered by Representative Schraa | |
| 2/12/2024 Asm. | Assembly Amendment 3 offered by Representative Schraa | |
| 2/13/2024 Asm. | LRB correction (Assembly Amendment 2) | |
| 2/14/2024 Asm. | Public hearing held | |
| 4/15/2024 Asm. | Failed to pass pursuant to Senate Joint Resolution 1 |
